If you enjoy to ask a scientist involved next to muscular dystrophy what do you ask?
Answers:
Read up on and ask about gene therapy for Duchenne's muscular dystrophy. There are exciting developments that convert DMD to a milder form (Becker's) with systemic nativity of a nonviral/nonimmunogenic vector.
Does Osteopontin pose a good target for specific treatment for amelioration of the fibotic changes in MD? Have you found another target close to Osteopontin that might be easier to treat?
Related Questions:
